The creation of a vaccine to protect against the myriad strains of the human immunodeficiency virus (HIV) may be possible, according to a new study conducted at the Uniformed Services University of the Health Sciences (USU).
Since HIV is extremely variable, its prevention requires a vaccine effective enough to stimulate the body to produce cross-reactive antibodies that can neutralise multiple viral strains.
AdvertisementThe latest study shows that the goal of induction of truly broad-spectrum neutralising antibodies may be achieved.
During the study, USU Professors Dr. Gerald Quinnan, Jr. and Dr. and Christopher Broder attempted to elicit cross-reactive antibodies in an animal model by immunising with a particular HIV-1 surface protein, namely R2 gp140, and an immune response-boosting component.
The researchers tested antibodies generated by the immunisations to determine their effectiveness in neutralising the infectivity of a variety of HIV-1 strains.
It was seen that the antibodies were capable of neutralising all 48 strains of HIV-1 tested.
The results are encouraging for vaccine development, as they show that it is possible to elicit a broad-spectrum antibody response.
The study entitled 'Extensively Cross-Reactive Anti-HIV-1 Neutralizing Antibodies Induced by gp140 Immunization' has been published in the Proceedings of the National Academy of Sciences.
PBubbles may Pave Way for Producing Nanoscale Electronic Components Shoe Shopping Augments Health of Fairer Sex! M
You May Also Like